Luteal phase support for assisted reproduction cycles

M van der Linden, K Buckingham… - Cochrane Database …, 2011 - cochranelibrary.com
Background Progesterone prepares the endometrium for pregnancy by stimulating
proliferation in response to human chorionic gonadotropin (hCG), which is produced by the …

Progesterone and the luteal phase: a requisite to reproduction

TB Mesen, SL Young - Obstetrics and Gynecology Clinics, 2015 - obgyn.theclinics.com
The normal menstrual cycle can be divided into two phases: follicular and luteal, which are
separated by ovulation and bookended by the first day of menstrual bleeding. The follicular …

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support …

H Tournaye, GT Sukhikh, E Kahler… - Human …, 2017 - academic.oup.com
STUDY QUESTION Is oral dydrogesterone 30 mg daily (10 mg three times daily [TID]) non-
inferior to micronized vaginal progesterone (MVP) 600 mg daily (200 mg TID) for luteal …

[HTML][HTML] Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support

RF Casper, EH Yanushpolsky - Fertility and sterility, 2016 - Elsevier
With significant improvements in cryopreservation technology (vitrification) the number of
frozen ET IVF cycles is increasing and may soon surpass in numbers and success rates …

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial

G Griesinger, C Blockeel, GT Sukhikh… - Human …, 2018 - academic.oup.com
STUDY QUESTION Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized
vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY …

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis

G Griesinger, C Blockeel, E Kahler, C Pexman-Fieth… - PLoS …, 2020 - journals.plos.org
The aim of this systematic review and meta-analysis was to conduct a comprehensive
assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …

Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction

G Griesinger, H Tournaye, N Macklon… - Reproductive …, 2019 - Elsevier
The pharmacological and physiological profiles of progestogens used for luteal phase
support during assisted reproductive technology are likely to be important in guiding clinical …

Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro …

X Zhu, X Zhang, Y Fu - Medicine, 2015 - journals.lww.com
A major cause of cycle cancellation during controlled ovarian hyperstimulation (COH) in
women undergoing in vitro fertilization (IVF) is the occurrence of premature luteinizing …

[HTML][HTML] Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles

T Child, SA Leonard, JS Evans, A Lass - Reproductive biomedicine online, 2018 - Elsevier
Vaginal progesterone via capsule, gel or tablet is the most common route for luteal phase
support (LPS) in Europe. Although there is a wealth of data comparing products used at …

Dydrogesterone use in early pregnancy

FG Mirza, A Patki, C Pexman-Fieth - Gynecological Endocrinology, 2016 - Taylor & Francis
Successful oocyte implantation and a favorable pregnancy outcome rely on optimal
progesterone levels. Therefore, progesterone deficiencies associated with infertility and …